Search Within

Julie T Feldstein

  1. "Ross Levine"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (4)
Groups
  1. Adult Leukemia (13)
  2. Center for Hematologic Malignancies (13)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (13)
  4. Department of Medicine (13)
  5. Executive Committee, Center for Hematologic Malignancies (13)
  6. GSK Faculty (13)

More Groups

People
  1. Ross Levine (13)
  2. Ahmet Dogan (6)
  3. Anas Younes (6)
  4. Andrew Zelenetz (6)
  5. Craig Moskowitz (6)
  6. Omar Abdel-Wahab (6)

More People

Years
  1. 2018 (1)
  2. 2016 (1)
  3. 2015 (1)
  4. 2014 (6)
  5. 2013 (3)
  6. 2011 (1)
Publications
  1. Blood (6)
  2. Cancer Discovery (1)
  3. Journal of Clinical Investigation (1)
  4. Journal of Clinical Oncology (1)
  5. Laboratory Investigation (1)
  6. Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Nature Publishing Group (2)
  3. American Association for Cancer Research (1)
  4. American Society for Clinical Investigation (1)
  5. American Society of Clinical Oncology (1)
  6. Elsevier Ltd (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • JAK2/IDH-mutant–driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
    Journal Article

    McKenney, A. S.; Lau, A. N.; Hanasoge Somasundara, A. V.; Spitzer, B.; Intlekofer, A. M.; Ahn, J.; Shank, K.; Rapaport, F. T.; Patel, M. A.; Papalexi, E.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells
    Journal Article

    Guryanova, O. A.; Lieu, Y. K.; Garrett-Bakelman, F. E.; Spitzer, B.; Glass, J. L.; Shank, K.; Martinez, A. B. V.; Rivera, S. A.; Durham, B. H.; Rapaport, F.; more...
    Leukemia (2016)

    Fulltext@MSK | Save
  • JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
    Journal Article

    Kleppe, M.; Kwak, M.; Koppikar, P.; Riester, M.; Keller, M.; Bastian, L.; Hricik, T.; Bhagwat, N.; McKenney, A. S.; Papalexi, E.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • A comprehensive clinical next generation sequencing-based assay can impact hematopathologic diagnosis in a significant subset of patients with hematologic malignancies
    Meeting Abstract

    Pichardo, J. D.; Feldstein, J. T.; Arcila, M.; Batlevi, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.; Tallman, M. S.; Stein, E. M.; Klimek, V. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Conditional loss of Dnmt3a results in myeloproliferation and liver-specific myeloid expansion
    Meeting Abstract

    Guryanova, O. A.; Lieu, Y.; Shank, K. R.; Rivera, S.; Garrett-Bakelman, F. E.; Glass, J.; Keller, M. D.; Pandey, S.; Tovbin, D.; Weinstein, A. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, R.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, I.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2013)

    Fulltext@MSK | Save